CEREBAIN BIOTECH CORP.
CEREBAIN BIOTECH CORP. (CBBT) is a publicly traded company in the Unknown sector. Across all available filings, 2 corporate insiders have executed 9 transactions totaling $0, demonstrating a neutral sentiment with $0 in net insider flow. The most recent transaction on Feb 19, 2018 involved a transaction of 160,000 shares valued at $28.8K.
CBBT Insider Activity Summary
Who Is Buying CBBT Stock?
No significant insider buying has been recorded for CBBT in the recent period.
Who Is Selling CBBT Stock?
No significant insider selling has been recorded for CBBT in the recent period.
Is CEREBAIN BIOTECH CORP. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CBBT is neutral with an Insider Alignment Score of 50/100 and a net flow of $0.
CBBT Frequently Asked Questions
Understanding CBBT Insider Activity
Insider trading at CEREBAIN BIOTECH CORP. (CBBT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 2 insiders are actively trading CBBT stock, having executed 9 transactions in the past 90 days. The most active insider is Eric Clemons (Executive), who has made 5 transactions totaling $1.4B.
Related Tools
Track CEREBAIN BIOTECH CORP. Insider Activity
Get notified when executives and directors at CBBT file new Form 4 transactions